G Medical Innovations Holdings Ltd (GMVDF)
- Previous Close
0.0101 - Open
0.0100 - Bid --
- Ask --
- Day's Range
0.0100 - 0.0140 - 52 Week Range
0.0060 - 0.5200 - Volume
4,398 - Avg. Volume
33,391 - Market Cap (intraday)
3.119M - Beta (5Y Monthly) -1.14
- PE Ratio (TTM)
-- - EPS (TTM)
-18.7600 - Earnings Date May 16, 2024 - May 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
gmedinnovations.comRecent News: GMVDF
Performance Overview: GMVDF
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GMVDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GMVDF
Valuation Measures
Market Cap
338.12k
Enterprise Value
2.14M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
--
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-223.32%
Return on Equity (ttm)
--
Revenue (ttm)
4.42M
Net Income Avi to Common (ttm)
-13.52M
Diluted EPS (ttm)
-18.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
295k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.87M
Research Analysis: GMVDF
Company Insights: GMVDF
GMVDF does not have Company Insights